Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Diabetes increases stent surgery risks

Written by | 8 Dec 2025

Patients with diabetes have an increased risk of complications after stent implantation, according to a study from Karolinska Institutet in Sweden published in Diabetes Care. The study emphasises… read more.

Health benefits of telemedicine in type 1 diabetes

Written by | 12 Nov 2025

People with type 1 diabetes achieved significantly better long-term blood glucose when their levels were monitored by healthcare professionals in real time, via a sensor under the skin,… read more.

Tzield accepted for expedited review by FDA for stage 3 type 1 diabetes through Commissioner’s National Priority Voucher pilot program – Sanofi

Written by | 28 Oct 2025

The FDA has accepted for expedited review the supplemental biologics license application (sBLA) for Tzield (teplizumab-mzwv) to delay the progression of stage 3 type 1 diabetes (T1D) in… read more.

Vegan diet helps people with type 1 diabetes cut insulin costs by 27%

Written by | 17 Oct 2025

A low-fat vegan diet that doesn’t limit calories or carbohydrates could help people with type 1 diabetes reduce insulin use and insulin costs, according to new research by… read more.

New review highlights impact of diabetes on bone health and fracture risk

Written by | 30 Jun 2025

A landmark narrative review published by the Bone and Diabetes Working Group of the  International Osteoporosis Foundation (IOF) Committee of Scientific Advisors reveals critical insights into how diabetes… read more.

Semaglutide and tirzepatide treatment leads to weight loss in type 1 diabetes

Written by | 14 Sep 2024

Treatment with semaglutide and tirzepatide led to significant weight loss and improved blood sugar control in overweight or obese patients with type 1 diabetes (T1D). Researchers reported this… read more.

Weekly insulin injections have the potential to be as effective in diabetes management as now-common daily injection regimes

Written by | 2 Nov 2023

Insulin icodec, a once-weekly basal injection to treat type 1 diabetes, has the potential to be as effective in managing the condition as daily basal insulin treatments, according… read more.

Is universal screening for type 1 diabetes around the corner?

Written by | 8 Oct 2023

The the latest data on  universal screening for type 1 diabetes (T1D) is reveiwed in a session at this year’s Annual Meeting of the European Association for the… read more.

‘MyDiaMate’, an app to strengthen mental health for adults with type 1 diabetes

Written by | 23 Mar 2023

International researchers –from the Netherlands, Germany, United Kingdom, and Spain– work together to develop an app that improves physical and emotional well-being in patients with type 1 diabetes… read more.

Artificial pancreas improves blood sugar control in young children with type 1 diabetes

Written by | 21 Mar 2023

An artificial pancreas improves blood sugar control in children ages 2 to 6 with type 1 diabetes, researchers reported on March 16, 2023 the NEJM/New England Journal of Medicine…. read more.

Testing a immunological drug as a new treatment for early type 1 diabetes

Written by | 29 Jan 2023

A large clinical study is now beginning on an approved drug for treating psoriasis. The drug will be tested on patients who were recently diagnosed with type 1… read more.

Covid-19 may increase diabetes risk in children

Written by | 10 Oct 2022

A large two-year study has found that young people infected with SARS-CoV-2 – the virus which causes Covid-19 – are at increased risk of new-onset type 1 diabetes…. read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.